Subtype
Malignant Urinary Tract Neoplasm
CI-CAN-00003252Explore in graph →
507 active trials14 approved drugs29 evidence items
- NCIt
- C192668
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003252Explore in graph →
Clinical trials
1,954 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (246)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00006476 | Suramin in Treating Patients With Recurrent Bladder Cancer | completed | Phase 1 | 15 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00829920 | The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease | completed | — | 44 | University of Colorado, DenverOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00002990 | Surgery and BCG in Treating Patients With Bladder Cancer | completed | Phase 3 | 1,288 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00014274 | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium | completed | Phase 2 / Phase 3 | 238 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | completed | Phase 3 | 608 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 16 | Jun 12, 2013 | clinicaltrials |
| NCT00072150 | Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00009867 | Arsenic Trioxide in Treating Patients With Urothelial Cancer | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00045630 | S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium | completed | Phase 2 | 77 | SWOG Cancer Research NetworkNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00963859 | Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder | completed | Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00002917 | Paclitaxel in Treating Patients With Early-Stage Bladder Cancer | completed | Phase 1 / Phase 2 | — | Mary Babb Randolph Cancer Center at West Virginia University HospitalsOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00006034 | Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer | completed | Phase 3 | — | IntracelINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00303654 | Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection | completed | N/A | 24 | Roei Medical Technologies Ltd.INDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01810445 | Endoscopic Subsurface Optical Imaging for Cancer Detection | completed | — | 26 | University of California, DavisOTHER | 0 | Mar 13, 2013 | clinicaltrials |
| NCT01801644 | Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer | completed | N/A | 60 | Barmherzige Brüder ViennaOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00006124 | Celecoxib in Treating Patients With Bladder Cancer | completed | Phase 2 / Phase 3 | 152 | National Cancer Institute (NCI)NIH | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00978991 | Duke Urology Database and Specimen Bank | completed | — | 87,820 | Duke UniversityOTHER | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00004122 | BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer | completed | Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00003759 | AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer | completed | Phase 2 | — | Anthra PharmaceuticalsINDUSTRY | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00055835 | S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium | completed | Phase 2 | 7 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00021099 | Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00003167 | Gene Therapy in Treating Patients With Advanced Bladder Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00005831 | Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT01276665 | Effects of Noradrenaline Administration Combined With Restrictive Intraoperative Fluid Substitution on Perioperative Outcome in Patients Undergoing Radical Cystectomy | completed | N/A | 190 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT01734798 | Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer | completed | Phase 3 | 198 | Cairo UniversityOTHER | 1 | Nov 28, 2012 | clinicaltrials |
| NCT00066612 | S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy | completed | Phase 2 | 45 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 2, 2012 | clinicaltrials |
| NCT00322699 | Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 22 | North Florida/South Georgia Veterans Health SystemOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00080795 | Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium | completed | Phase 2 | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 22, 2012 | clinicaltrials |
| NCT00014144 | S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract | completed | Phase 2 | 31 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00006026 | Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract | completed | Phase 2 | 21 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00006351 | SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract | completed | Phase 2 | 34 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00023842 | BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | completed | Phase 2 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00694798 | Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder(STCC) | completed | Phase 1 | 22 | Cadila PharnmaceuticalsINDUSTRY | 1 | May 3, 2012 | clinicaltrials |
| NCT01373398 | Safety and Pharmacokinetic Study of EO9(Intravesical Instillation) | completed | Phase 1 | 11 | Handok Inc.INDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00744744 | Health-Related Quality of Life in Patients With Bladder Cancer | completed | — | 138 | David LatiniOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00772018 | Quality of Life and Symptom Management in Patients With Bladder Cancer | completed | — | 28 | David LatiniOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01426126 | Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum | completed | Phase 2 | 37 | Asan Medical CenterOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00971256 | Urine Cytology and Utility in Bladder Recurrence | completed | — | 10 | Corewell Health EastOTHER | 0 | Nov 23, 2011 | clinicaltrials |
| NCT00622973 | USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases | completed | Phase 3 | 130 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01149174 | Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer(EMDA/PRE-TUR) | completed | Phase 3 | 352 | University of Rome Tor VergataOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT00335491 | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | completed | N/A | 49 | University of UtahOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT01442519 | Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer(BCG/EMDA-MMC) | completed | Phase 3 | 212 | University of Rome Tor VergataOTHER | 1 | Sep 28, 2011 | clinicaltrials |
| NCT00792025 | Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer | completed | Phase 2 | 80 | Institut CurieOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00186277 | Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer | completed | Phase 2 | 10 | Stanford UniversityOTHER | 1 | Mar 30, 2011 | clinicaltrials |
| NCT00859768 | The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | completed | N/A | 568 | Netherlands Open UniversityOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00330707 | Combined Use of BCG and Interferon Alpha in Bladder Cancer | completed | Phase 2 / Phase 3 | 140 | National University Hospital, SingaporeOTHER | 1 | Mar 4, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Jun 26, 2013source: clinicaltrials